Idiopathic Inflammatory Myopathies
📧 Sign up to get email alerts when something new happens for Idiopathic Inflammatory Myopathies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune Diseases [EARLY_Phase 1]
A Phase 1 targeted CD19 CAR-T therapy trial for autoimmune diseases has been suspended.
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases [Phase 4]
Phase 4 clinical trial update on the recombinant herpes zoster vaccine in patients with autoimmune rheumatic diseases; the study is active b…
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: A Study of Imvotamab in Active, Refractory Idiopathic Inflammatory Myopathies [Phase 1]
A Phase 1 study of Imvotamab in active, refractory idiopathic inflammatory myopathies has been terminated (Status: TERMINATED).
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult Dermatomyositis [Phase 2, Phase 3]
Clinical trial update reporting results for sodium thiosulfate in calcinosis associated with dermatomyositis, with Phase 2 and Phase 3 studi…
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: JAK 1/2 Inhibitor, Baricitinib, in the Treatment of Adult IIM [Phase 2]
A Phase 2 clinical trial evaluating baricitinib (JAK1/2 inhibitor) for adult idiopathic inflammatory myopathies has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: Study Evaluating Efficacy and Safety of Froniglutide (PF1801) in Patients With Idiopathic Inflammatory Myopathy [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of Froniglutide (PF1801) in patients with idiopathic inflammatory myopathies, in…
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: Clinical Characteristics and Mechanism Research of Inhibitors of Janus Kinase in the Idiopathic Inflammatory Myopathies [Phase 2]
Phase 2 clinical trial update investigating Janus kinase inhibitors in idiopathic inflammatory myopathies, focusing on characteristics and m…
-
CLINICAL_TRIALS trial_result · 2019-07-26Clinical Trial Update: Treating Idiopathic Inflammatory Myopathies Related Reduced Bone Mineral Density With Denosumab or Zoledronic Acid [Phase 3]
Phase 3 clinical trial comparing denosumab vs zoledronic acid for bone mineral density in patients with idiopathic inflammatory myopathies a…